TIM-3 blockade in E0771 mice also elicited a statistically significant reduction in tumor size at the post-treatment timepoint but showed decreased Ltb expression and NF-κB signaling when compared to the anti-PD-1-treated group. Here, NFKB1 is linked to neoplasm.